Amino Acids & Building Blocks(氨基酸 & 组成单元)

Cat.No. 产品名称 Information

GC63781 (R)-BAY-899

GC63768 Oxythiamine diphosphate ammonium

GC63748 SPOP-IN-6b dihydrochloride

GC63712 XL388-C2-amide-PEG9-NH2 hydrochloride

GC63698 Leucomalachite green-d5

GC63697 BSc3094

GC63685 (6R,7S)-Cefminox sodium heptahydrate

GC63677 VPC-80051 racemate VPC-80051 is an potent inhibitor of hnRNP A1 splicing activity that targets hnRNP A1 RBD and reduces AR-V7 messenger levels in 22Rv1 CRPC cell line.

GC63673 ABT-384

GC63665 Benzylacyclouridine

GC63657 N,N,N′,N′-Tetracyclohexyl-3-oxapentanediamide A calcium ionophore

GC63638 Acetone-d6

GC63637 Esfenvalerate

GC63633 N7-Methyl-guanosine-5’-triphosphate-5’-adenosine

GC63629 cis-2-Butene-1,4-diol

GC63626 ZINC05007751 ZINC05007751 is a potent NIMA-related kinase NEK6 inhibitor with an IC50 of 3.4 μM, shows antiproliferative activity against a panel of human cancer cell lines and displays a synergistic effect with Cisplatin and Paclitaxel in a BRCA2 mutated ovarian cancer cell line. DMSO is not recommended to dissolve platinum-based drugs, which can easily lead to drug inactivation.

GC63625 N-Palmitoyl-L-glutamine

GC63618 Antrafenine

GC63614 Trichloroacetonitrile

GC63600 Piperonyl alcohol

GC63589 NSC668394

GC63588 Palmitoyl glutamic acid

GC63587 Dichlormid

GC63586 FR054 FR054 is a novel inhibitor of the Hexosamine Biosynthetic Pathway (HBP) enzyme PGM3 with a remarkable anti-breast cancer effect.

GC63573 Cannabigerol monomethyl ether An Analytical Reference Standard

GC63557 PW0787

GC63553 PTPN22-IN-1

GC63551 AZD-CO-Ph-PEG4-Ph-CO-AZD

GC63542 L-Histidine benzyl ester bistosylate

GC63535 ALV2

GC63530 Acid Ceramidase-IN-1

GC63526 (S)-ErSO

GC63525 Valiloxibic acid

GC63510 BPK-25

GC63509 BPK-21

GC63508 R-(+)-Mono-desmethylsibutramine

GC63506 Curcumin-β-D-glucuronide

GC63493 ELOVL1-IN-1 An inhibitor of ELOVL1

GC63488 Ethaselen

GC63480 Obafistat

GC63475 Deltamethrin-d5 An internal standard for the quantification of deltamethrin

GC63424 Givosiran

GC63420 ABR-238901 ABR-238901 is a novel S100A8/A9 blocker that potently inhibits S100A8/A9 interaction with its receptors RAGE (receptor for advanced glycation endproducts) and TLR4 (toll-like receptor 4).

GC63409 SG3199-Val-Ala-PAB

GC63401 BPH-652

GC63368 Patisiran sodium

GC63361 CR-1-30-B

GC63347 Peptide 78

GC63344 PFM39

GC63339 OSBPL7-IN-1